These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 37220607)
1. Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy. Kikushige Y Blood Cell Ther; 2022 Dec; 5(Spec Edition):S1-S5. PubMed ID: 37220607 [TBL] [Abstract][Full Text] [Related]
2. [TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in human acute myeloid leukemia]. Sakoda T; Kikushige Y Rinsho Ketsueki; 2023; 64(6):547-552. PubMed ID: 37407480 [TBL] [Abstract][Full Text] [Related]
3. [A TIM-3/galectin-9 autocrine stimulatory loop drives self-renewal of human myeloid leukemia stem cells and leukemia progression]. Kikushige Y Rinsho Ketsueki; 2016 Apr; 57(4):412-6. PubMed ID: 27169443 [TBL] [Abstract][Full Text] [Related]
5. TIM-3 signaling hijacks the canonical Wnt/β-catenin pathway to maintain cancer stemness in acute myeloid leukemia. Sakoda T; Kikushige Y; Miyamoto T; Irifune H; Harada T; Hatakeyama K; Kunisaki Y; Kato K; Akashi K Blood Adv; 2023 May; 7(10):2053-2065. PubMed ID: 36745103 [TBL] [Abstract][Full Text] [Related]
6. Immunoprofiling of leukemic stem cells CD34+/CD38-/CD123+ delineate FLT3/ITD-positive clones. Al-Mawali A; Gillis D; Lewis I J Hematol Oncol; 2016 Jul; 9(1):61. PubMed ID: 27465508 [TBL] [Abstract][Full Text] [Related]
7. Acute myeloid leukemia stem cell markers in prognosis and targeted therapy: potential impact of BMI-1, TIM-3 and CLL-1. Darwish NH; Sudha T; Godugu K; Elbaz O; Abdelghaffar HA; Hassan EE; Mousa SA Oncotarget; 2016 Sep; 7(36):57811-57820. PubMed ID: 27506934 [TBL] [Abstract][Full Text] [Related]
8. Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia. de Figueiredo-Pontes LL; Pintão MC; Oliveira LC; Dalmazzo LF; Jácomo RH; Garcia AB; Falcão RP; Rego EM Cytometry B Clin Cytom; 2008 May; 74(3):163-8. PubMed ID: 18200595 [TBL] [Abstract][Full Text] [Related]
9. Identification of TIM-3 as a Leukemic Stem Cell Surface Molecule in Primary Acute Myeloid Leukemia. Kikushige Y; Miyamoto T Oncology; 2015; 89 Suppl 1():28-32. PubMed ID: 26551150 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of TIM-3 expression pattern at diagnosis in patients with t(8;21) acute myeloid leukemia. Wang J; Yang L; Dao FT; Wang YZ; Chang Y; Xu N; Chen WM; Jiang Q; Jiang H; Liu YR; Qin YZ Leuk Lymphoma; 2022 Jan; 63(1):152-161. PubMed ID: 34405769 [TBL] [Abstract][Full Text] [Related]
11. Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells. Lee WS; Ye Z; Cheung AMS; Goh YPS; Oh HLJ; Rajarethinam R; Yeo SP; Soh MK; Chan EHL; Tan LK; Tan SY; Chuah C; Chng WJ; Connolly JE; Wang CI Mol Cancer Ther; 2021 Sep; 20(9):1702-1712. PubMed ID: 34158344 [TBL] [Abstract][Full Text] [Related]
13. TIM-3 in normal and malignant hematopoiesis: Structure, function, and signaling pathways. Kikushige Y Cancer Sci; 2021 Sep; 112(9):3419-3426. PubMed ID: 34159709 [TBL] [Abstract][Full Text] [Related]
14. Live kinase B1 maintains CD34 Wang H; Wang X; Xin N; Qi L; Liao A; Yang W; Liu Z; Zhao C Mol Cell Biochem; 2017 Oct; 434(1-2):25-32. PubMed ID: 28397012 [TBL] [Abstract][Full Text] [Related]
16. Specific Depletion of Leukemic Stem Cells: Can MicroRNAs Make the Difference? Martiáñez Canales T; de Leeuw DC; Vermue E; Ossenkoppele GJ; Smit L Cancers (Basel); 2017 Jun; 9(7):. PubMed ID: 28665351 [TBL] [Abstract][Full Text] [Related]
17. Delineation of target expression profiles in CD34+/CD38- and CD34+/CD38+ stem and progenitor cells in AML and CML. Herrmann H; Sadovnik I; Eisenwort G; Rülicke T; Blatt K; Herndlhofer S; Willmann M; Stefanzl G; Baumgartner S; Greiner G; Schulenburg A; Mueller N; Rabitsch W; Bilban M; Hoermann G; Streubel B; Vallera DA; Sperr WR; Valent P Blood Adv; 2020 Oct; 4(20):5118-5132. PubMed ID: 33085758 [TBL] [Abstract][Full Text] [Related]
18. Attenuation of microRNA-126 expression that drives CD34+38- stem/progenitor cells in acute myeloid leukemia leads to tumor eradication. de Leeuw DC; Denkers F; Olthof MC; Rutten AP; Pouwels W; Schuurhuis GJ; Ossenkoppele GJ; Smit L Cancer Res; 2014 Apr; 74(7):2094-105. PubMed ID: 24477595 [TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact and Phenotype of Residual Acute Myeloid Leukemia Stem Cells. Jaddaoui S; Bencharef H; Lamchahab M; Quessar A; Oukkache B Clin Lab; 2022 Jun; 68(6):. PubMed ID: 35704721 [TBL] [Abstract][Full Text] [Related]
20. Cluster of differentiation 96 as a leukemia stem cell-specific marker and a factor for prognosis evaluation in leukemia. DU W; Hu Y; Lu C; Li J; Liu W; He Y; Wang P; Cheng C; Hu YU; Huang S; Yao J; Zheng J Mol Clin Oncol; 2015 Jul; 3(4):833-838. PubMed ID: 26171191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]